ELVN Enliven Therapeutics, Inc.
Healthcare$41.54-1.68%ClosedMarket Cap: $2.53B
As of 2026-05-25
Institutional Ownership Summary
Investors Holding
127
13F Shares
62,307,228
Ownership %
100.3%
New Positions
21
Increased Positions
66
Closed Positions
28
Reduced Positions
44
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| 192,297 | 2.40% | ||
| Virtus Biotech Clinical Trials ETF | 16,173 | 1.80% | |
| Fidelity Disruptive Medicine ETF | 17,123 | 1.21% | |
| Tema Oncology ETF | 42,777 | 1.04% | |
| 124,406 | 0.47% | ||
| iShares U.S. Pharmaceuticals ETF | 124,406 | 0.47% | |
| 99,196 | 0.31% | ||
| iShares Micro-Cap ETF | 99,196 | 0.31% | |
| iShares Biotechnology ETF | 322,556 | 0.15% | |
| 319,687 | 0.10% | ||
| iShares Russell 2000 Growth ETF | 319,687 | 0.10% | |
| Avantis U.S. Small Cap Equity ETF | 55,379 | 0.09% | |
| iShares ESG Aware MSCI USA Small-Cap ETF | 43,825 | 0.08% | |
| 36,056 | 0.07% | ||
| Dimensional - US Small Cap ETF | 176,387 | 0.05% | |
| 966,241 | 0.05% | ||
| iShares Russell 2000 ETF | 966,241 | 0.05% | |
| Schwab U.S. Small-Cap ETF | 215,247 | 0.04% | |
| Global X - Russell 2000 ETF | 17,975 | 0.04% | |
| 195,031 | 0.04% |